News summary

Berlin Heals Initiates International Randomized, Double-Blind, Sham-Controlled C-MIC IV Trial

Source: PR Newswire • Published: 18 Nov 2026, 10:05

Summarized by Masters of Longevity from PR Newswire.

The C‑MIC IV trial started and enrolled its first patient under double‑blind sham control.

Berlin Heals Initiates International Randomized, Double-Blind, Sham-Controlled C-MIC IV Trial
Key Takeaways
  • Sixty patients will be randomized to active or sham treatment.
  • Participants have symptomatic reduced‑EF heart failure above 20%.
  • The trial is randomized double‑blind and sham‑controlled.
Read the full article at PR Newswire ↗

Continue exploring

Recommended MoL Picks

MoL PickMelatonin and Heart Failure: What the Evidence Actually ShowsA 2025 study linked melatonin use with heart failure. A 2026 analysis found no significant association. Their different designs explain why the question remains open.MoL PickApple Brings Longevity to the Wrist. What Will It Change?Apple’s new Health Age, readiness and movement tools bring long-term health into everyday view. The opportunity is turning that information into useful action.MoL PickCan Exergaming Improve Balance? What Older Adults Should KnowMotion-controlled games may make balance practice easier to repeat. The evidence supports a structured adjunct—not a fall-proofing shortcut.